ARCHIVES

NIH director; Targets Increases Favor Established Researchers

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”

July 21, 2006

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy

November 9, 1990

Uncertainty Lingers After NCI Meeting With Army; Activists Offer Advice

November 6, 1992